Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/7aadc2b4-93a2-43f5-b352-2bca7b3eeb41/
WST
West Pharmaceutical Services IncSnapshot 2026-06-07 · 0.0w · Fresh
Strategy Eligibility
4 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
ROE 18%
📈
Consistent Earners
Noneyr
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
12-1 46%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
RAM 1.11
V
Value Analysis
Cheapness relative to fundamentals
3.0%ile
P/E
42.0×
P/S
7.1×
P/B
7.6×
E/P
0.0238
FCF Yield
0.043
EBITDA/EV
0.036
SH Yield
0.003
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
97.00000000
/100 — 1=cheapest
VC2 (Trending Value)
96.00000000
/100
VC3 (Buyback)
96.00000000
/100
P/E of 42.0x is premium-priced — the market is paying up for expected growth. VC2 score of 96.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
90.0%ile
ROE
0.181
ROA
0.132
Net Margin
0.169
Op Margin
0.208
GPA
0.284
D/E
0.37
Current
2.71
F-Score
7/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.112
Earn Growth
0.162
Stability
0.136
lower=better
Accruals
-0.042
lower=better
5yr Consist
Yes
Conservative balance sheet with D/E of 0.37.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
82.0%ile
6M Return
12.4%
12M Return
40.4%
12-1 Mom
45.5%
Risk-Adj
1.11
Vol 252d
41.0%
Vol 60d
76.2%
↑ Expanding
Max DD 12M
-22.2%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 46% is very strong — a clear uptrend. Near-term vol (76%) is expanding vs long-term (41%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.41
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 500 peers
Sector Value %ile
1.2%
Sector Quality %ile
91.6%
P/E z-score
0.29
P/B z-score
0.22
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Quality Momentum — Expensive
Strong quality (90th) and momentum (82th) but expensive (3th value). Premium priced — watch for mean reversion.
Hot but Volatile
Strong momentum (82th) but high volatility (41%). Momentum could reverse sharply.
Quality at a Premium
High quality (90th) but expensive (3th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (76%) significantly exceeds 252-day (41%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
24.3% avg (7 factors)
Quality
B
72.1% avg (8 factors)
Momentum
B
69.5% avg (4 factors)
Risk
C
48.3% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.410 | —0 | — | |
| Value %ile | 0.030 | —1 | — | |
| Quality %ile | 0.900 | —1 | — | |
| Momentum %ile | 0.820 | —1 | — | |
| F-Score | 7.000 | —1 | — | |
| Confidence | 1.000 | —1 | — | |
| Volatility | 0.410 | —1 | — |
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
41.96
Earnings Yield (E/P)
0.0238
Price / Sales
7.07
Price / Book
7.61
Price / Cash Flow
31.83
FCF Yield
4.3%
EBITDA / EV
3.6%
Sales Yield (1/P·S)
0.1433
Shareholder Yield
Div + net buyback / mktcap
0.3%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
18.1%
Return on Assets
13.2%
Net Margin
16.9%
Operating Margin
20.8%
Gross Profit / Assets
Novy-Marx GPA
28.4%
Debt / Equity
0.37
Current Ratio
2.71
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.042
MomentumPrice trend strength over different horizons
6M Return
12.4%
12M Return
40.4%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
45.5%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
1.11
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
11.2%
Earnings Growth (YoY)
16.2%
Earnings Stability (CV)
Lower = more stable
0.136
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
7
Dividend Yield
0.3%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
97
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
96
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
96
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity